Nirogy Therapeutics Opens New Lab and Office Space as Headquarters Near Boston to Expand Operations

BOSTON, July 15, 2021 – Nirogy Therapeutics Inc., a privately-held biotechnology company developing novel small molecules to target cellular transporters, today announced the opening of new 10,000 square foot laboratory and office space in Framingham, Massachusetts. This new space will allow Nirogy to create up to 35 new jobs of highly skilled biotech positions.

Nirogy Therapeutics Opens New Lab

From left to right:  Dennis McWilliams/Sante,  Vincent Sandanayaka/Nirogy,  Ron DePinho/Sporos,  Peter Feinberg/Sporos.

“As Nirogy expands, we want to ensure that our research benefits from all of the available resources in the biotech industry as we strategically position ourselves in a vibrant and world-renowned biotech region. Our expansion serves to accelerate our potential to advance current programs to the clinic and provides new opportunities to attract top-tier talent to the team. The move into a larger space is a critical milestone in our growth to realize our vision of creating a path to end patient suffering and we thank everyone who helped us reach this point,” stated Vincent Sandanayaka, Ph.D., founder and CEO of Nirogy.

This new space houses sophisticated biotechnology and scientific equipment to expand operations as well as administrative offices. Nirogy recently opened the new facility with a ribbon-cutting ceremony attended by management and key stakeholders and plans to significantly increase the headcount to fill the space in the coming months.

About Nirogy

Nirogy Therapeutics is a biotechnology company based in Boston, MA, developing novel small molecules to target cellular transporters. The company is currently advancing a class of small molecules intended to disrupt metabolic and immune mechanisms operative in the tumor microenvironment. Follow-on platform programs are targeting additional disease pathways in oncology as well as autoimmune diseases.

More Posts


Send Us A Message

Scroll to Top

This website uses cookies to ensure you get the best experience on our website.

Vincent P. Sandanayaka, Ph.D.


At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint occaecati cupiditate non provident, similique sunt in culpa qui officia deserunt mollitia animi, id est laborum et dolorum fuga. Et harum quidem rerum facilis est et expedita distinctio. Nam libero tempore, cum soluta nobis est eligendi optio cumque nihil impedit quo minus id quod maxime placeat facere possimus, omnis voluptas assumenda est, omnis dolor repellendus. Temporibus autem quibusdam et aut officiis debitis aut rerum necessitatibus saepe eveniet ut et voluptates repudiandae sint et molestiae non recusandae. Itaque earum rerum hic tenetur a sapiente delectus, ut aut reiciendis voluptatibus maiores alias consequatur aut perferendis doloribus asperiores repellat